Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Summit Therapeutics Stock Jumps as Lung Cancer Treatment Gains Traction

Summit Therapeutics (NASDAQ:SMMT) is a Miami-based biopharmaceutical company that is focused on discovery, ...

SMMT : 8.39 (+3.71%)
Why Summit Therapeutics Stock Is Sinking Today

Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy.

SMMT : 8.39 (+3.71%)
5 Top-Rated Russell 2000 Stocks Crushing the Market in 2024

With the Russell 2000 index taking a dip in 2024, these five top-rated RUT stocks are outshining their parent index and the broader market.

$SPX : 5,431.60 (-0.04%)
IWM : 198.73 (-1.59%)
GS : 446.46 (+0.02%)
AVO : 10.26 (-1.72%)
GEO : 13.05 (-0.46%)
LE : 14.42 (-2.24%)
PAYS : 3.87 (-3.85%)
SMMT : 8.39 (+3.71%)
Why Summit Therapeutics Stock Crushed the Market This Week

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 78.59 (-0.62%)
SMMT : 8.39 (+3.71%)
Chart of the Day: Summit Therapeutics Begins to Soar

Caution: This company has had legal issues in the past. It is highly speculative. The Chart of the Day belongs to the oncology company Summit Therapeutics (SMMT) . I found the stock by using Barchart's...

SMMT : 8.39 (+3.71%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.39 (+3.71%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.39 (+3.71%)
Why Shares of Summit Therapeutics Slumped on Tuesday

The company's shares have been falling since it announced earnings late last week.

SMMT : 8.39 (+3.71%)
Why Shares of Summit Therapeutics Soared This Week

Summit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.

SMMT : 8.39 (+3.71%)
Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it has determined its first two indications in non-small cell lung cancer (NSCLC) in which to...

SMMT : 8.39 (+3.71%)

Barchart Exclusives

Should You Buy the Dip in DocuSign After Earnings?
Digital solutions provider DocuSign tanked after posting its Q1 results, and analysts slashed its price target in response. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar